Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ENVB | Enveric Biosciences | $3.85 | $2.03 | 111.54% | 155M | $3.4M | $1.71$17.84 |
| PBM | Psyence Biomedical | $13.00 | $5.40 | 71.05% | 39.6M | $2.3M | $1.92$74.94 |
| FGI | Fgi Industries | $9.50 | $3.00 | 46.11% | 2.4M | $13M | $2.41$12.62 |
| JLHL | Julong | $9.20 | $2.85 | 44.90% | 1.4M | $136M | $2.70$17.49 |
| CMPS | Compass Pathways Plc | $9.52 | $2.86 | 42.94% | 1.1M | $640M | $2.25$10.21 |
| VNCE | Vince | $4.50 | $1.10 | 32.35% | 1.1M | $45M | $1.02$4.65 |
| LVLU | Lulu's Fashion Lounge | $11.86 | $2.86 | 31.78% | 87.9K | $26M | $2.98$32.32 |
| AGPU | Axe Compute | $4.57 | $1.05 | 29.83% | 363.3K | $19M | $1.03$32.10 |
| INV | Innventure | $5.97 | $1.37 | 29.79% | 5.5M | $368M | $2.36$6.96 |
| MGRT | Mega Fortune | $150.72 | $34.56 | 29.75% | 36.2K | $1.6B | $1.50$170.00 |
| ATXG | Addentax Group | $7.68 | $1.60 | 26.32% | 143.3K | $4.7M | $3.32$27.90 |
| FLWS | 1-800-Flowers.com | $4.81 | $0.94 | 24.13% | 5.7M | $248M | $2.89$8.44 |
| NRXP | NRx Pharmaceuticals | $3.13 | $0.58 | 22.75% | 4.2M | $84M | $1.62$3.84 |
| BDRX | Biodexa Pharmaceuticals Plc | $4.26 | $0.78 | 22.41% | 155.1K | $1.6M | $2.86$96.50 |
| LFMD | LifeMD | $4.99 | $0.90 | 22.00% | 3.3M | $196M | $2.56$15.84 |
| ATAI | AtaiBeckley | $4.91 | $0.88 | 21.80% | 43.8M | $1.5B | $1.29$6.75 |
| SST | System1 | $2.61 | $0.46 | 21.39% | 11M | $17M | $1.35$15.00 |
| DFSC | Defsec Technologies | $2.35 | $0.41 | 21.38% | 2M | $3.9M | $0.22$15.37 |
| MXL | MaxLinear | $31.83 | $5.56 | 21.16% | 7M | $2.3B | $9.07$33.14 |
| BTM | Bitcoin Depot | $6.40 | $1.10 | 20.75% | 1.8M | $60M | $1.91$48.16 |
| WIMI | WiMi Hologram Cloud | $2.39 | $0.41 | 20.71% | 1M | $47M | $1.56$5.85 |
| NPT | Texxon | $4.75 | $0.79 | 19.82% | 814.4K | $88M | $2.79$22.38 |
| BLD | TopBuild | $489.80 | $79.49 | 19.37% | 200.1K | $12B | $273.87$559.47 |
| SILA | Sila Realty Trust | $30.40 | $4.87 | 19.06% | 8.6M | $1.4B | $21.94$30.55 |
| CAR | Avis Budget Group | $587.29 | $93.43 | 18.92% | 4.5M | $17B | $78.71$589.90 |
| LEGN | Legend Biotech | $25.15 | $3.98 | 18.80% | 5.7M | $3.9B | $16.24$45.30 |
| BCAB | BioAtla | $5.45 | $0.86 | 18.74% | 101.5K | $7.6M | $3.92$71.50 |
| POET | Poet Technologies | $8.61 | $1.35 | 18.53% | 41.6M | $659M | $3.58$9.41 |
Related Articles
Featured Article
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
Matthew Benjamin|Apr 20, 2026
Trump is easing approval for psychedelic treatments for mental disorders.
The Psychedelic Revolution in Mental Healthcare
Motley Fool Staff|Apr 17, 2026
Founders of the Integrative Psychiatry Institute, Dr. Will Van Derveer and Keith Kurlander, discuss their new book, Psychedelic Therapy: A Revolutionary Approach to Restoring Mental Health and Reclaiming Your Life.
5 Emerging Tech Stocks I'm Buying on This Sharp Pullback
George Budwell, PhD|Nov 15, 2025
The recent sell-off is an opportunity for long-term investors.
8 AI Stocks I'd Buy Right Now
George Budwell, PhD|Nov 13, 2025
From proven megacaps to speculative small caps, these eight stocks span the AI infrastructure stack at different risk levels.
Why Poet Technologies Stock Soared 16.2% in October
Scott Levine|Nov 9, 2025
This pure-play AI stock caught investors' attention last month for a couple of different reasons.
Is Poet Technologies Stock a Buy?
George Budwell, PhD|Oct 9, 2025
A $75 million capital raise and partnerships with industry giants are fueling optimism, but revenue remains minimal.
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
Cory Renauer|Jul 20, 2025
Should You Buy the Dip on Compass Pathways Stock?
Alex Carchidi|Jun 12, 2024
Nothing is going wrong, but one of its peers just hit a serious snag.
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Alex Carchidi|May 21, 2024
Psychedelic medicines are rapidly gaining legitimacy on several fronts.
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.
Alex Carchidi|Feb 19, 2024
The lofty target is closer to being within reach than it may seem at first.
